JAK2 and neoplasm: Further in vivo validation using a mouse ESCA xenograft model showed that SPP1 overexpression significantly increased tumor volume while either SPP1 knockdown or pharmacological inhibition of the JAK2‐STAT3 pathway reduced tumor volume in a synergistic manner with radiotherapy.